Xiaoxi Huang

Title: The Innovative Contributions of Xiaoxi Huang

Introduction

Xiaoxi Huang is a prominent inventor based in Beijing, China. She has made significant contributions to the field of immunology through her innovative research and patenting efforts. Her work focuses on enhancing the immune response, which has important implications for vaccine development.

Latest Patents

Xiaoxi Huang holds a patent for the "Porcine CD28 receptor, gene for encoding same, and application of same." This patent describes a porcine CD28 receptor molecule that can enhance T cell activation, proliferation, and cytokine secretion when stimulated by an antigen. The patent outlines a protein consisting of an amino acid sequence represented by SEQ ID NO:2, as well as a gene for coding the porcine CD28 receptor, with the nucleotide sequence shown as SEQ ID NO:1. This innovation has the potential to significantly improve the acquired immune response of a host and enhance the effectiveness of vaccines.

Career Highlights

Xiaoxi Huang is affiliated with the Zhonghao Chenguang Research Institute of Chemical Industry Company Limited, where she continues to advance her research in immunology. Her work has garnered attention for its potential applications in vaccine development and immune response enhancement.

Collaborations

Xiaoxi Huang collaborates with esteemed colleagues, including Xun Suo and Xianyong Liu, to further her research initiatives. These collaborations contribute to a dynamic research environment that fosters innovation and discovery.

Conclusion

Xiaoxi Huang's contributions to the field of immunology through her patent on the porcine CD28 receptor exemplify her commitment to advancing scientific knowledge and improving vaccine efficacy. Her work is a testament to the importance of innovation in addressing global health challenges.